Angiopoietin-2 concentration in serum is associated with severe asthma phenotype

Allergy, Asthma and Clinical Immunology

Volumn 12, Issue 1, 2016, Pages

  Makowska, Joanna S ^a   Cieślak, Małgorzata ^a   Jarzebska, Marzanna ^a   Lewandowska Polak, Anna ^a   Kowalski, Marek L ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiopoietins; Pathogenesis; Severe asthma

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BUDESONIDE; GLUCOCORTICOID; OSTEOPONTIN; PREDNISONE; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; ASTHMA; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; MALE; PHENOTYPE; RESPIRATORY FUNCTION;

EID: 84959364327     PISSN: 17101484     EISSN: 17101492     Source Type: Journal    
DOI: 10.1186/s13223-016-0112-6     Document Type: Article

References (34)

1. Bousquet J. Global initiative for asthma (GINA) and its objectives. Clin Exp Allergy J Br Soc Allergy Clin Immunol. 2000;30(Suppl 1):2-5.
2. Janson C. The importance of airway remodelling in the natural course of asthma. Clin Respir J. 2010;4(Suppl 1):28-34. doi: 10.1111/j.1752-699X.2010.00194.x.
3. Wilson JW, Kotsimbos T. Airway vascular remodeling in asthma. Curr Allergy Asthma Rep. 2003;3(2):153-8.
4. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol. 2001;107(2):295-301. doi: 10.1067/mai.2001.111928.
5. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med. 2001;164(10 Pt 2):S39-45.
6. Orsida BE, Li X, Hickey B, Thien F, Wilson JW, Walters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax. 1999;54(4):289-95.
7. Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J. 2000;15(6):1014-21.
8. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932-6. doi: 10.1038/nature04478.
9. O'Leary AP, Fox JM, Pullar CE. Beta-adrenoceptor activation reduces both dermal microvascular endothelial cell migration via a cAMP-dependent mechanism and wound angiogenesis. J Cell Physiol. 2014. doi: 10.1002/jcp.24716.
10. He J, Jing Y, Li W, Qian X, Xu Q, Li FS, et al. Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis. PLoS One. 2013;8(2):e56647. doi: 10.1371/journal.pone.0056647.
11. Meyer N, Akdis CA. Vascular endothelial growth factor as a key inducer of angiogenesis in the asthmatic airways. Curr Allergy Asthma Rep. 2013;13(1):1-9. doi: 10.1007/s11882-012-0317-9.
12. Zanini A, Chetta A, Imperatori AS, Spanevello A, Olivieri D. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res. 2010;11:132. doi: 10.1186/1465-9921-11-132.
13. Saharinen P, Bry M, Alitalo K. How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol. 2010;17(3):198-205. doi: 10.1097/MOH.0b013e3283386673.
14. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest. 2007;131(4):1035-41. doi: 10.1378/chest.06-2758.
15. Kanazawa H, Tochino Y, Asai K. Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy. J Allergy Clin Immunol. 2008;121(2):390-5. doi: 10.1016/j.jaci.2007.09.026.
16. Moon KY, Lee PH, Park SW, Park CS, Jang AS. Serum angiopoietin is associated with lung function in patients with asthma: a retrospective cohort study. BMC Pulm Med. 2014;14:143. doi: 10.1186/1471-2466-14-143.
17. Samitas K, Zervas E, Vittorakis S, Semitekolou M, Alissafi T, Bossios A, et al. Osteopontin expression and relation to disease severity in human asthma. Eur Respir J. 2011;37(2):331-41. doi: 10.1183/09031936.00017810.
18. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med. 2000;162(6):2341-51.
19. Burney P, Potts J, Makowska J, Kowalski M, Phillips J, Gnatiuc L, et al. A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project. Allergy. 2008;63(7):865-71. doi: 10.1111/j.1398-9995.2008.01716.x.
20. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007;62(10):1111-8. doi: 10.1111/j.1398-9995.2007.01409.x.
21. Tseliou E, Bakakos P, Kostikas K, Hillas G, Mantzouranis K, Emmanouil P, et al. Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma. Allergy. 2012;67(3):396-402. doi: 10.1111/j.1398-9995.2011.02768.x.
22. Petta V, Bakakos P, Tseliou E, Kostikas K, Simoes DC, Konstantellou E, et al. Angiopoietins 1 and 2 in sputum supernatant of optimally treated asthmatics: the effect of smoking. Eur J Clin Invest. 2015;45(1):56-62. doi: 10.1111/eci.12379.
23. Koksal BT, Ozbek OY, Bayraktar N, Yazici AC. Evaluation of angiopoietin 1 and 2, vascular endothelial growth factor, and tumor necrosis factor alpha levels in asthmatic children. Allergy Asthma Proc. 2014;35(6):482-8. doi: 10.2500/aap.2014.35.3793.
24. De Silva D, Dagher H, Ghildyal R, Lindsay M, Li X, Freezer NJ, et al. Vascular endothelial growth factor induction by rhinovirus infection. J Med Virol. 2006;78(5):666-72. doi: 10.1002/jmv.20591.
25. Psarras S, Volonaki E, Skevaki CL, Xatzipsalti M, Bossios A, Pratsinis H, et al. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J Allergy Clin Immunol. 2006;117(2):291-7. doi: 10.1016/j.jaci.2005.11.005.
26. Tabruyn SP, Colton K, Morisada T, Fuxe J, Wiegand SJ, Thurston G, et al. Angiopoietin-2-driven vascular remodeling in airway inflammation. Am J Pathol. 2010;177(6):3233-43. doi: 10.2353/ajpath.2010.100059.
27. Feistritzer C, Mosheimer BA, Sturn DH, Bijuklic K, Patsch JR, Wiedermann CJ. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol. 2004;114(5):1077-84. doi: 10.1016/j.jaci.2004.06.045.
28. Lemieux C, Maliba R, Favier J, Theoret JF, Merhi Y, Sirois MG. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood. 2005;105(4):1523-30. doi: 10.1182/blood-2004-09-3531.
29. Simoes DC, Vassilakopoulos T, Toumpanakis D, Petrochilou K, Roussos C, Papapetropoulos A. Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma. Am J Respir Crit Care Med. 2008;177(12):1314-21. doi: 10.1164/rccm.200708-1141OC.
30. Lee KS, Lee KY, Kim SR, Park HS, Park SJ, Min KH, et al. Blockade of airway inflammation and hyper-responsiveness by an angiopoietin-1 variant, COMP-Ang1. Exp Mol Med. 2007;39(6):733-45. doi: 10.1038/emm.2007.80.
31. Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, et al. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005;314(2):738-44. doi: 10.1124/jpet.105.086553.
32. Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007;132(6):1882-9. doi: 10.1378/chest.07-0713.
33. Etulain J, Negrotto S, Tribulatti MV, Croci DO, Carabelli J, Campetella O, et al. Control of angiogenesis by galectins involves the release of platelet-derived proangiogenic factors. PLoS One. 2014;9(4):e96402. doi: 10.1371/journal.pone.0096402.
34. Devouassoux G, Pachot A, Laforest L, Diasparra J, Freymond N, Van Ganse E, et al. Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy. 2008;63(1):125-31. doi: 10.1111/j.1398-9995.2007.01558.x.